InsidersTradesSigma
Explore the full record of transactions filed by MCDADE MARK, Director. Officer active across 1 companies, notably Icosavax, Inc.. In total, 2 filings have been logged. Total volume traded: €271k. The latest transaction was filed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Mark McDade is a Director at Icosavax, Inc. As a board member, he is involved in the governance of the company and strategic decision-making. McDade has a strong background in the biopharmaceutical sector, enabling him to contribute to the organization's development.